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Abstract
Social and psychosocial factors are thought to have an effect on the course of atopic eczema. The aim of this scoping
review was to search for and summarize observational studies that investigated the effects of (psycho-)social factors on
symptoms in atopic eczema and to identify research gaps. We searched PubMed and PsycINFO for literature published
between 1 January 1989 and 31 December 2019 using a systematic search strategy. We included observational studies
that analysed the effect of (psycho-)social factors on symptom severity in atopic eczema patients. Reviews and non-ob-
servational studies, articles with research on animals, and articles with languages other than English or German were
excluded. We identified 17 observational studies that met the inclusion criteria. Several studies found significant results
for an exacerbating effect of stress on atopic eczema severity. Although coping and social support does not seem to
moderate the effect of stress, coping strategies might mediate the impact that stress has on symptoms. Depression is
associated with atopic eczema severity. The effect of depression as a consequence of atopic eczema severity is stronger
than the effect as an exacerbating factor. Illness identity, anger, frustration and psychosomatic states have been found
to affect atopic eczema symptoms. For attachment security, anxiety and social status, contradictory results were found.
Statistically non-significant results were reported for personality, being in a partnership, satisfaction with the partnership,
childhood experiences and body consciousness. Only the association between psychosocial stress and atopic eczema
symptom severity seems robust. To date, other (psycho-)social factors, especially protective and health-promoting fac-
tors, were analysed only in a few studies, mostly with low sample sizes and cross-sectional design. Biopsychosocial
interactions between stress, protective factors and the course of atopic eczema as well as the psycho-neuroimmunolog-
ical mechanisms underlying those interactions are considered fields for future research contributions.
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Atopic eczema is a chronic skin disease with increasing preva-
lence in most parts of the world.1 The main symptoms of which
are pruritus (itch) and dry skin.2 Additionally, patients with
atopic eczema often suffer from sleeplessness and stigmatiza-
tion.3,4 Therefore, they generally have a lower quality of life
and worse mental health than healthy individuals.4 There is no
cure to date for the disease, but there are multiple options to
treat and alleviate the symptoms. Those treatment options are
often connected to financial strain since there is no guaranteed
coverage of costs of basic therapy by insurance companies.
Therefore, patients do not only suffer from symptoms and their
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consequences, but also from investment of money and time
into the treatment.5,6
Referring to a biopsychosocial model of the disease, not only
biological factors like irritants and allergens can impact symp-
tom severity, but also psychosocial factors like stress.7 We know
that several allergens (such as food, house dust mite and pollen),
seasonality, bacterial infections with Staphylococcus aureus, tex-
tiles, detergents, UV-light and stress can cause the symptoms or
increase symptom severity.8 On the other hand, we do not know
what kind of factors – besides medical treatment and interven-
tions – can decrease symptom severity or even lead to remission
of atopic eczema.
Focusing on a vulnerability-stress model of atopic eczema,
not only risk factors but also protective and health-promoting
factors are relevant factors within the interplay of biopsychoso-
cial environment and individual symptom severity.9 Psychoso-
cial factors, in general, are psychological factors which interact
with the social environment. The social environment includes
factors on macrolevel (e.g., socioeconomic factors), mesolevel
(e.g., working conditions) and microlevel (e.g., social support).
(Psycho-)social factors can affect atopic eczema symptom sever-
ity via psycho-neuroimmunological mechanisms or behavioural
pathways.10,11
For children with atopic eczema, it is shown that psychologi-
cal and educational interventions can improve symptoms.12
Educational interventions have been found to improve atopic
eczema management in adults.13 Especially in adults, it is
assumed that complex psycho-neuroimmunological mechanisms
play an important role for the onset and the course of the dis-
ease.14 However, well-conducted studies on self-management
interventions are lacking.15
This scoping review on the associations between (psycho-)so-
cial factors and atopic eczema symptom severity in observational
studies aims to identify research gaps and show where future
research contributions in this field are needed.
Methods
A scoping review was performed for the literature published in
the last 30 years, i.e., between 01 January 1989 and 31 Decem-
ber 2019 on PubMed and PsycINFO, including EPUB first arti-
cles (last research performed on January 27, 2020). Literature
published prior to 1989 had been previously reviewed by Mar-
tin (1996) and Schubert (1989).16,17 A scoping review is a quite
new method for synthesizing evidence, to identify how research
is done on a certain topic or if there are existing knowledge
gaps.18
The systematic search strategy consisted of three parts. First,
we identified ‘atopic eczema’ in titles or abstracts using MesH
terms and expanded the query to also include ‘neurodermitis’
and ‘neurodermatitis’. Second, we looked for ‘symptom severity’
by using synonyms for symptoms (e.g., ‘skin condition’ or
‘flare’) and measures of eczema symptoms, based on the system-
atic review on atopic eczema outcome measures of Schmitt
et al.19 Third, we looked for ‘psychosocial factors’, using
umbrella terms like ‘psychosocial’, ‘social’ or ‘psychological’, but
also psychologic disorders (e.g., ‘depression’), specific stressors
(e.g., ‘life event’) and protective or health-promoting factors
(e.g., ‘coping’). Terms such as ‘sense of coherence’ or ‘resilience’
did not lead to more search results and were therefore left out of
the search strategy. The three parts were connected with the
Boolean operator ‘AND’ and were limited to the search in titles
and abstracts. An overview of the full search strategy is provided
in Table 1.
All studies identified with this search strategy were included
in the first step of the review.
After screening titles, abstracts and full texts, the resulting
studies were then determined to be included or excluded from
the next step of analysis, based on a set of exclusion criteria.
Studies were excluded if (i) atopic eczema symptom severity
was not defined as outcome, (ii) social or psychosocial factors
were not defined as exposure, (iii) the study population was
non-human, (iv) the study was non-observational (i.e.,
reviews, guidelines, interventional studies, case studies and
studies with n < 10), and (v) the study was written in other
languages than German or English. We documented the first
reason for exclusion that we noticed while reading titles,
abstracts and full texts, although some studies met more than
one exclusion criteria.
Table 1 Search strategy used in Pubmed and PsychInfo (title and
abstract)
Terms searched for in Pubmed and PsycInfo (title and abstract), from
01 January 1989 – 31 December 2019
Atopic eczema Atopic Dermatitides or Atopic Dermatitis or
Dermatitides, Atopic or Neurodermatitis, Atopic or
Atopic Neurodermatitides or Atopic Neurodermatitis
or Neurodermatitides, Atopic or Neurodermatitis,
Disseminated or Disseminated Neurodermatitides or
Disseminated Neurodermatitis or Neurodermatitides,
Disseminated or Eczema, Atopic or Atopic eczema or





skin condition or symptom severity or severity or
symptom or symptoms or POEM or SCORAD or EASI
or NESS or ADAM or ADASI or BCSS or IGADA or
Leicester index or OSAAD or RL score or SA-EASI or
SASSAD or SCORAD or SSS or TISS or BCSS or
FSSS or SIS or TBSA or WAZ-S or itch or flare or




psychosocial or psychological or social or behavioural
or behavioural or educational or mental or emotion or
stress or job or traumatic or life event or anxiety or
depression or depressive or ADHD or ADD or
attention deficit or attachment or self-esteem or locus
of control or self-efficacy or coping
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Table 2 Summary of scoping review results
References Design Number of atopic








Longitudinal 50 (30.6  10.7 years,
64% female, Australia)
















143 (19–89 years, 61.5%
female, Canada)†
Depression (CRSD) Itch severity (‘How much is
your rash itching at the
present time?’, 10 point scale







50 (11–22 years, 70%
female, USA)
Stress (APES), social support






Yes (stress, coping), no
(social support); moderation
analysis revealed: social
support and coping are no
moderating factors in the











Percentage of affected area
(<20% mild, 20% to <50%









1457 (only age groups
reported: 28.9%
<10 years, 26.6% 10–
20 years, 36.8%
>20 years, 51.8% female,
Japan)§
Subjective emotional distress in
response to the earthquake
(yes/no)









Longitudinal 137 (5–10 years, 53%
female, United Kingdom)
Social class (father’s
job/mother’s job for single










124 (28.6  9.4 years,
68.5% female, Germany)
Attachment style (RSQ) Atopic eczema severity (NSI),























85 (12–52 years, 61.2%
female, Japan)
Anxiety (STAI) Atopic eczema severity




Longitudinal 25 (2 months–12 years,
44% female, Ireland)















Yes (anxiety and itch), no
(all other psychosocial






















89 (18–60 years, 66.3%
female, Poland)




(SCORAD), itch (4-item itch
questionnaire, VAS)
Yes
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Finally, the remaining full texts which met the inclusion crite-
ria were reviewed and summarized in Table 2. In addition, the
results were narrated and depicted in a schematic summary
(Fig. 2). Meta-analysis was not meaningful as the measures for
psychosocial factors and symptom severity were quite heteroge-
nous and only a few studies per psychosocial factor exist. More-
over, the aim of this scoping review was to provide an overview
of observational studies and to identify research gaps instead of
quantifying the effect of psychosocial factors on atopic eczema
severity.
Results
We identified 772 studies via Pubmed and 128 studies via Psy-
chInfo. After removing the duplicates, 832 studies remained.
First, the titles and abstracts were screened. In this step, we
excluded 795 studies. The most common reason for exclusion
was an inadequate outcome or exposure. Other articles were
excluded on the basis of their non-observational design, lan-
guage barrier or animal study population.
The second step was to screen the remaining 37 studies by
full-text analysis. We excluded another 17 studies due to inade-
quate outcome or exposure, and 3 studies because they were
non-observational.
Ultimately, 17 studies were included in the final review (see
Fig. 1, Table 2). The characteristics of the reviewed studies are
shown in Table 2.
Psychosocial stress and coping
Stress was the most analysed factor in the included studies. For
the measurement of stress, each study used a different
method.16,20–24 Nevertheless, all cross-sectional and longitudinal
studies found a significant effect of stress on symptom severity
Table 2 Continued
References Design Number of atopic
















Yes (illness identity), no (all











Itch intensity (VAS) Yes (all variables correlated
with itch, multiple mediation
analysis revealed: itch-
related coping is a mediator












class: ‘White collar’ workers;
lower class: ‘Blue collar’





SCORAD < 37 vs.
SCORAD > 36)
Yes (social status and
SCORAD dichotomized),






201 (0–18 years, 51.8%
female, USA)
Structural racism (race, family
income, education of caregiver,
living environment, residential
segregation)
AD severity (mild = no class
one topical steroid or systemic
therapy required, moderate =
BSA > 10% + class one
topical steroid treatment




Abbreviations: AAS, Adult Attachment Scale; APES, Adolescent Perceived Events Scale; BDI, Beck Depression Inventory; CMI, Cornell Medical Index; CRI-
Y, Coping Responses Inventory – Youth Form; CRSD, Carroll Rating Scale for Depression; EASI, Eczema Area and Severity Index; EBS, Ehrenfelder Inven-
tory of Coping; IAS, Interaction Anxiousness Scale; IPQ, Illness Perception Questionnaire; MAS, Manifest Anxiety Scale; MSQ, Marburger Skin Question-
naire; NSI, Neurodermitis-Schweregrad-Index; PBI, Parental Bonding Instrument; PFB, Hahlweg’s Partnership Questionnaire; REST-Q, Recovery-Stress
Questionnaire; RSQ, Relationship Scales Questionnaire; SAS, Self-rating Anxiety Scale; SCORAD, Severity Scoring of Atopic Dermatitis; SDS, Self-rating
Depression Scale; SRRS, Social Readjustment Rating Scale; STAI, State-Trate Anxiety Inventory; TCI, Temperament and Character Inventory; VAS, Visual
Analogue Scale.
†Age and sex were reported for all patients that were included in the study (n = 252), not for atopic eczema patients only
‡The study of Martin 1996 was published as a dissertation, all other studies were published as articles
§Sex was reported only for patients included in the regression analysis
¶Data on age was received from the publication on the superordinate research project on the effects of stress management in atopic eczema50
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with correlation coefficients between r = 0.2 and r = 0.5. Some
studies adjusted for co-factors such as sex, age, age of atopic
eczema onset, coping, social support, environmental factors and
medication.16,21,24
Contradictory findings were reported for the effect of coping
on eczema symptoms.16,24,25 Disease-specific coping was identi-
fied as a mediating factor in the association of stress and itch,24
but coping was no moderating factor in the association of stress
and eczema symptoms.16
Emotions
King and Wilson analysed the correlation of anger felt, anger
expressed, anger suppressed and frustration, with skin condition
in atopic eczema patients.20 They found significant correlations
for all emotions with correlation coefficients between r = 0.09
and r = 0.19.
Mental health
Mental health was another aspect that was often analysed. For
anxiety, contradictory results were found.20,26–29 Interestingly,
two studies even used the same measure for anxiety, but did not
come to the same results.28,29 Hashizume et al.28 did not find
any association between anxiety and atopic eczema severity,
measured with the State-Trait Anxiety Inventory (STAI) and a
visual analogue scale (VAS) for itch, respectively. However, Oh
et al. found an association between anxiety (STAI) and itch
(VAS).29 At the same time, neither Oh et al. nor Hashizume
et al. could find an association between anxiety and eczema
severity measured with EASI or SCORAD.28,29
Although one study did not find an association between
depression and atopic eczema symptoms,29 all other studies that
examined this relationship found associations between depres-
sion and atopic eczema symptom severity.20,26,27,30 Correlation
coefficients ranged from 0.21 to 0.51. A longitudinal study
points out that depression might be a consequence, rather than
an influencing factor, of atopic eczema symptoms.20
Patients with moderate atopic eczema were more prone to
psychosomatic symptoms than controls.26
Social status
Three studies investigated social status in association to atopic
eczema severity.31–33 All of the studies were conducted on chil-
dren. One of them could not find any association between social
status, as measured by occupations of the parents, and atopic
eczema symptoms. However, a statistically significant association
was found in the second study, where social status was also mea-
sured by occupations of the parents and children with SCORAD
>36 were compared to children with a lower SCORAD.32 The
third study measured social status according to family income
and education of the caregivers.33 An association with both
social class indicators was found. Moreover, this study also

























Search in PubMed (n = 772) 
and PsychInfo (n = 128)
Articles screened by title and 
abstract (n = 832)
Full-text articles assessed for eligibility
(n = 37)
Studies included after full-text review
(n = 17)
Articles excluded n = 795
• Inadequate outcome/exposure n = 421
• Non-observational study n = 266
• Language n = 62
• Non-human population n = 46 
Full-text articles excluded, with reasons, n = 20:
• Inadequate outcome/ exposure, n = 17
• Non-observational study, n = 3
Duplicates removed
n = 68
Figure 1 Flow Chart of the review process.
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such as race, living environment or residential segregation. All of
those aspects were associated with atopic eczema severity, espe-
cially in black children.33
Relationship with others –attachment, partnership and
social support
Contradictory results for the association between attachment
security and atopic eczema severity were found.34,35
No statistically significant results were reported for the associ-
ation of being in a partnership, partnership satisfaction or social
support, with atopic eczema symptoms.35 No moderating effect
of social support in the association of stress and symptoms was
shown.16
Other: Illness perception, childhood experiences,
personality and body consciousness
Illness identity was significantly correlated with symptom sever-
ity, while other illness perceptions were not (i.e., belief that psy-
chological factors cause the disease, belief that chance causes the
disease, perceptions about the timeline of the disease and belief
in having control over the disease).25
Additionally, no significant results were reported for associa-
tions of childhood experiences, personality or private body con-
sciousness with atopic eczema symptoms.27,29
In Fig. 2 a schematic summary of the review results on the
associations between (psycho-)social factors and atopic eczema
symptom severity is given.
Discussion
Within this scoping review, we investigated what kind of social
and psychosocial factors were associated with atopic eczema
symptom severity in observational studies. We found several
studies that assumed an exacerbating effect of psychosocial stress
on symptom severity. Coping strategies might mediate the
association between stress and symptoms, while coping and
social support does not seem to moderate the association. One
study also observed effects of illness identity, anger, frustration
and psychosomatic states on atopic eczema symptoms. Depres-
sion was correlated with atopic eczema symptoms, but the effect
of eczema symptoms on depression seems stronger than the
effect of depression on eczema symptoms. Contradictory results
were observed for anxiety, attachment security and social status.
Statistically non-significant associations were found for child-
hood experiences, body consciousness, living in a partnership
and satisfaction with the partnership. In general, only the associ-
ation between stress and symptom severity seems robust. For all
other factors, only a few studies with mostly low sample size and
cross-sectional design exist.
Psychosocial stress – Association or causation?
Psychosocial stress was associated with the symptom severity of
atopic eczema patients in all studies that analysed the effect of
stress. Even longitudinal studies showed that psychosocial stress
might have an effect on symptom severity. While in most cases,
mental stress seems to exacerbate symptoms, it may also be able
to reduce symptom severity.21 According to the criteria of
causality defined by Hill,36 the existing studies point to a possi-
bly causal inference: the correlation coefficients found in studies
analysing the association between stress and atopic eczema
severity indicate that the association’s strength is mild to moder-
ate. Moreover, the finding of the effect of stress on symptoms
was consistent across observations of a diverse variety of people,
places, circumstances and times. Regarding specificity, we can-
not say that the association is very specific. On the one hand,
psychosocial stress can cause many different kinds of diseases
and symptoms, yet on the other hand, atopic eczema symptoms
can be amplified by a variety of factors. Nevertheless, Hill states














Figure 2 Schematic Summary of the review results. The solid line between psychosocial stress and atopic eczema symptom severity
shows that this association seems robust, while the other associations (dotted lines) need to be approved or disproved by further
research. The figure shows only factors that were associated with atopic eczema symptoms in the reviewed studies. Factors that were
not analysed yet (e.g., resilience) or factors that did not have an effect in the reviewed studies (e.g., social support) are not shown in this
figure, although they could play an important role in the context of atopic eczema.
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for a non-causal inference.36 Another criterion which seems to
be met is the temporality of the association, since a few longitu-
dinal studies show that stress can be measured before increased
symptom severity shows up. Although eczema can also cause
psychosocial stress, e.g., because of financially straining and
time-consuming therapies, stress also seems to exacerbate symp-
toms. This might in turn lead to some kind of vicious cycle.
Regarding the biological gradient or the dose-dependency, we
cannot make any conclusion at the moment. It is hard to mea-
sure the dose of stress, because the stress appraisal is very indi-
vidual. ‘Checklists’ like the social readjustment rating scale of
Holmes and Rahe, try to quantify the amount of stress.37 How-
ever, according to the transactional stress model by Lazarus, the
amount of stressors do not necessarily correlate with the stress
response, because of the individual stress appraisal.38 Lazarus
et al.38 also define stress as an emotion; analogously emotions
such as frustration and anger might affect symptoms in a similar
way as stress does. Biological plausibility is given to how stress
could cause symptoms in atopic eczema, based on theories of
psycho-neuroimmunological mechanisms.11 The association
between stress and symptoms is coherent, not only with existing
research, but also with the experiences of the patients. Moreover,
experimental evidence points to relaxation techniques which
appear to reduce symptom severity in atopic eczema.39
Mental health issues – A consequence of atopic eczema?
An association between depression and symptom severity was
found in most studies. Depression can be interpreted as a stres-
sor and can therefore increase symptom severity, yet one study
pointed out that depression might rather be a consequence than
an impacting factor on atopic eczema symptoms.20 In this
review, we looked for studies which defined psychosocial factors
as exposure. Many other studies, that defined depression or anx-
iety as an outcome, were not included in this review. A recently
published review summarizes the literature on the psychosocial
comorbidity of atopic eczema.40 Depression can also be a result
of stigmatization.41 Many atopic eczema patients feel stigmatized
because of the visibility of the disease or the assumed failure of
management. Especially women with atopic eczema are more
vulnerable to feelings of stigmatization and therefore also to
depression,42 possibly because social norms of beauty and health
are rather associated with the female than with the male gen-
der.43
For anxiety, contradictory results were found in cross-sec-
tional studies. One reason for contradictory results might be the
different measurement of anxiety and eczema symptoms. Also,
small sample sizes and low statistical power can lead to statisti-
cally non-significant results. Sampling bias in terms of different
age groups or different proportions of male and female patients
can be another reason for different findings. More studies are
needed to approve or disprove the association between anxiety
and atopic eczema symptoms.
Social status – Social gradient in eczema symptoms?
Although one study did not find any association between social
status and eczema symptoms, two other studies found associa-
tions pointing towards a social gradient of atopic eczema symp-
tom severity. While the lack of socioeconomic resources seems
to worsen atopic eczema symptoms, having high socioeconomic
resources could be a protective factor in atopic eczema. This is
in contrast to the prevalence, which seems to be higher in high
socioeconomic status groups (reversed social gradient).44 How-
ever, the reversed social gradient in atopic eczema prevalence
might be a consequence of underreporting in low socioeconomic
status groups.44 Future studies should continue to investigate
the social gradient of atopic eczema severity. They should not
only concentrate on children, but also on adults, and measure
the social status in a multidimensional way. Since education
programs seem to be an effective tool for the improvement of
eczema management, education and health literacy might be
health-promoting factors in atopic eczema.13 Also, income could
be a protective factor for atopic eczema patients, as the costs for
eczema treatment are quite extensive.6 Since it is shown that the
symptom severity is worse in black children, the intertwined risk
of environment, race and social status in the context of struc-
tural racism should also be kept in mind as a potential risk fac-
tor.33
Relationship with others – a protective factor?
Few studies hypothesized that insecure attachment might
increase symptom severity in eczema, but contradictory results
were found. More studies are needed to investigate this relation-
ship, as a secure attachment could possibly be a protective factor,
and therefore a new dimension for an interventional or preven-
tive approach.
Social support and partnership did not have an effect on
symptom severity, but the studies analysing the association
between social support and symptoms had a small sample size
and therefore a low statistical power. Social support might be a
protective or health-promoting factor as well, because it is able
to buffer the negative effect of stress.45 Another study with big-
ger sample size and higher power should have a look on the
moderating effect of social support in the association between
stress and atopic eczema severity.
Other psychosocial factors – only few studies looking at
health-promoting factors
Looking at factors other than psychosocial stress, mental health,
social status or relationship with others, only one study reported
an association between illness representations and eczema symp-
tom severity. One additional study investigated personality and
private body consciousness in association with eczema symp-
toms, but did not find a significant result.
In general, other social and psychosocial factors are not well
researched, especially factors that might improve the symptoms.
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From a salutogenetic perspective not only risk factors, but also
health-promoting and protective factors should be research
objectives.46 The focus is rather on disease prevention than on
health promotion. In atopic eczema, health promotion could
mean promoting the remission of symptoms, i.e., increasing the
number and the duration of symptom-free phases. For example,
a proactive topical therapy can help to increase the duration of
symptom-free phases in atopic eczema.47 It has not yet been
investigated if (psycho-)social factors could support the effect of
proactive topical therapy, help atopic eczema patients to become
healthy, and live with less, or even without, flares.
Finally, the responsibility for good health does not only lie in
individuals, i.e., in physicians and patients. Changes on a struc-
tural level, e.g., working conditions or attitudes towards psy-
chosocial factors, are also necessary to reduce stressors and make
(psycho-)social health-promoting factors available for everyone.
Strengths and limitations
The strengths of this scoping review are the inclusion of various
psychosocial factors in the systematic search strategy and the
search in different databases. It gives an overview of the current
state of the research on psychosocial factors and atopic eczema
symptoms. This review also has some limitations. No protocol
was published before the review started and only one reviewer
screened all articles. The research was performed in titles and
abstracts only and we included observational studies only. This
leads to incomplete results. On the other hand, reviews for inter-
ventional studies already exist.12,15,48 The review was limited to a
specific period. Various outcome measures were included in the
review, which makes objective result comparison challenging. In
general, conclusions have to be drawn with caution since only a
handful of studies for each psychosocial factor were published.
Conclusion
This scoping review supports the hypothesis that the effect of
psychosocial stress increases symptom severity. Nevertheless,
more well-conducted studies are needed with regard to psy-
chosocial factors other than stress as possible in register stud-
ies.49 Especially factors that might buffer the effect of stress, i.e.,
protective and health-promoting factors, could be the objective
of future research. Better knowledge of biopsychosocial interac-
tions between stressors and protective factors might help to bet-
ter understand the course of atopic eczema. In the long term,
this might help to improve and personalize interventions and
create structures to stay or become healthy in times of omnipre-
sent psychosocial strain. Especially for adults with atopic eczema,
where psycho-neuroimmunological mechanisms seem to play an
important role, this might be helpful, but also for other stress-
induced complaints.
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